HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kohzoh Imai Selected Research
Kohzoh Imai Research Topics
Disease
143
Neoplasms (Cancer)
01/2024 - 01/2002
38
Colorectal Neoplasms (Colorectal Cancer)
03/2016 - 01/2002
29
Carcinoma (Carcinomatosis)
04/2014 - 01/2002
24
Stomach Neoplasms (Stomach Cancer)
07/2014 - 01/2002
17
Carcinogenesis
01/2016 - 01/2003
15
Neoplasm Metastasis (Metastasis)
01/2024 - 01/2003
15
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2017 - 01/2002
14
Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2003
13
Adenoma (Adenomas)
01/2016 - 06/2002
12
Adenocarcinoma
08/2019 - 01/2003
11
Immunoglobulin G4-Related Disease
01/2016 - 01/2010
11
Mikulicz' Disease
11/2014 - 04/2005
10
Colonic Neoplasms (Colon Cancer)
03/2013 - 02/2003
9
Rheumatoid Arthritis
06/2012 - 04/2003
8
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2014 - 08/2006
7
Microsatellite Instability
01/2019 - 08/2002
7
Autoimmune Pancreatitis
01/2015 - 04/2005
7
Colitis
04/2014 - 06/2003
6
Breast Neoplasms (Breast Cancer)
01/2022 - 08/2004
5
Esophageal Squamous Cell Carcinoma
02/2014 - 05/2007
5
Fibrosis (Cirrhosis)
04/2013 - 07/2010
5
Liver Neoplasms (Liver Cancer)
05/2011 - 03/2004
5
Multiple Myeloma
03/2011 - 01/2002
4
Malignant Mesothelioma
01/2024 - 01/2017
4
Hepatocellular Carcinoma (Hepatoma)
08/2011 - 06/2008
4
Ulcerative Colitis
06/2009 - 01/2003
3
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2019 - 04/2008
3
Inflammation (Inflammations)
01/2016 - 01/2003
3
Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2016 - 10/2005
3
Tuberculosis (Tuberculoses)
01/2016 - 10/2007
3
Dacryocystitis (Dacryoadenitis)
11/2014 - 01/2012
3
Sialadenitis
11/2014 - 01/2012
3
Hematologic Neoplasms (Hematological Malignancy)
12/2012 - 03/2002
3
Systemic Scleroderma (Systemic Sclerosis)
06/2012 - 06/2004
3
Biliary Tract Neoplasms (Biliary Tract Cancer)
02/2012 - 09/2005
3
Hemorrhage
11/2008 - 03/2002
Drug/Important Bio-Agent (IBA)
24
Proteins (Proteins, Gene)
FDA Link
01/2024 - 01/2003
20
Messenger RNA (mRNA)
IBA
03/2013 - 10/2002
18
Monoclonal Antibodies
IBA
01/2024 - 03/2002
18
DNA (Deoxyribonucleic Acid)
IBA
04/2014 - 03/2002
17
Immunoglobulin G (IgG)
IBA
01/2016 - 01/2002
15
MicroRNAs (MicroRNA)
IBA
09/2022 - 04/2008
15
Small Interfering RNA (siRNA)
IBA
01/2022 - 07/2005
14
Calcibiotic Root Canal Sealer
IBA
01/2016 - 10/2004
14
Decitabine
FDA Link
03/2013 - 12/2003
13
Biomarkers (Surrogate Marker)
IBA
01/2016 - 02/2004
11
Mucins
IBA
01/2018 - 01/2002
11
Methyltransferases
IBA
03/2016 - 12/2003
11
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
02/2014 - 10/2003
10
Insulin-Like Peptides
IBA
03/2013 - 10/2003
9
beta Catenin
IBA
11/2009 - 04/2005
9
Matrix Metalloproteinases (MMPs)
IBA
08/2009 - 01/2003
9
Complementary DNA (cDNA)
IBA
06/2007 - 11/2002
8
hydrogen sulfite (bisulfite)
IBA
10/2015 - 12/2003
8
Histones (Histone)
IBA
03/2013 - 01/2002
7
Peptides (Polypeptides)
IBA
01/2023 - 08/2005
7
Transcription Factors (Transcription Factor)
IBA
10/2018 - 01/2002
7
Histone Deacetylase Inhibitors
IBA
06/2011 - 12/2003
6
Therapeutic Uses
IBA
09/2022 - 09/2004
6
Ligands
IBA
08/2019 - 03/2002
6
Immunoglobulins (Immunoglobulin)
IBA
01/2016 - 01/2006
6
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2013 - 06/2004
6
Indicators and Reagents (Reagents)
IBA
12/2012 - 03/2002
6
Matrix Metalloproteinase 7 (Matrilysin)
IBA
08/2009 - 01/2003
5
Antigens
IBA
01/2024 - 02/2002
5
Antibodies
IBA
01/2018 - 01/2003
5
ErbB Receptors (EGF Receptor)
IBA
01/2017 - 03/2002
5
Glucocorticoids
IBA
01/2015 - 10/2005
5
Interferon-gamma (Interferon, gamma)
IBA
01/2013 - 03/2004
5
Bortezomib (Velcade)
FDA Link
11/2012 - 06/2004
5
Phosphotransferases (Kinase)
IBA
06/2009 - 06/2005
5
Enzymes
IBA
07/2008 - 11/2002
5
romidepsin (FK228)
FDA Link
04/2008 - 06/2004
5
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
08/2007 - 01/2002
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2007 - 03/2003
4
Steroids
IBA
01/2015 - 02/2004
4
Paraffin
IBA
08/2014 - 01/2003
4
Formaldehyde (Formol)
FDA Link
08/2014 - 01/2003
4
Acids
IBA
02/2014 - 06/2004
4
Insulin-Like Growth Factor II (Somatomedin A)
IBA
02/2012 - 12/2004
4
Interleukin-2 (IL2)
IBA
10/2011 - 03/2002
4
Interferons
IBA
05/2011 - 06/2009
4
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
09/2006 - 08/2003
3
Oligonucleotides
IBA
09/2022 - 10/2002
3
Insulin (Novolin)
FDA Link
01/2017 - 01/2002
3
Chromatin
IBA
01/2016 - 08/2007
3
Long Noncoding RNA
IBA
01/2016 - 03/2012
3
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
01/2015 - 10/2008
3
Antineoplastic Agents (Antineoplastics)
IBA
04/2014 - 03/2003
3
Dextran Sulfate
IBA
04/2014 - 02/2011
3
Proteasome Inhibitors
IBA
11/2012 - 06/2004
3
Autoantibodies
IBA
08/2012 - 02/2006
3
Insulin-Like Growth Factor I (IGF-1)
IBA
02/2012 - 10/2003
3
Bispecific Antibodies
IBA
10/2011 - 03/2002
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2011 - 08/2004
3
Dexamethasone (Maxidex)
FDA Link
Generic
03/2011 - 04/2005
Therapy/Procedure
63
Therapeutics
01/2024 - 03/2002
15
Drug Therapy (Chemotherapy)
01/2019 - 04/2003
8
Immunotherapy
01/2024 - 03/2002
4
Aftercare (After-Treatment)
04/2013 - 12/2003